| Literature DB >> 26824643 |
Max Keller1, Kilian K Kuhn1, Jürgen Einsiedel2, Harald Hübner2, Sabrina Biselli1, Catherine Mollereau3, David Wifling1, Jaroslava Svobodová1, Günther Bernhardt1, Chiara Cabrele4, Patrick M L Vanderheyden5, Peter Gmeiner2, Armin Buschauer1.
Abstract
Derivatization of biologically active peptides by conjugation with fluorophores or radionuclide-bearing moieties is an effective and commonly used approach to prepare molecular tools and diagnostic agents. Whereas lysine, cysteine, and N-terminal amino acids have been mostly used for peptide conjugation, we describe a new, widely applicable approach to peptide conjugation based on the nonclassical bioisosteric replacement of the guanidine group in arginine by a functionalized carbamoylguanidine moiety. Four arginine-containing peptide receptor ligands (angiotensin II, neurotensin(8-13), an analogue of the C-terminal pentapeptide of neuropeptide Y, and a neuropeptide FF analogue) were subject of this proof-of-concept study. The N(ω)-carbamoylated arginines, bearing spacers with a terminal amino group, were incorporated into the peptides by standard Fmoc solid phase peptide synthesis. The synthesized chemically stable peptide derivatives showed high receptor affinities with Ki values in the low nanomolar range, even when bulky fluorophores had been attached. Two new tritiated tracers for angiotensin and neurotensin receptors are described.Entities:
Mesh:
Substances:
Year: 2016 PMID: 26824643 DOI: 10.1021/acs.jmedchem.5b01495
Source DB: PubMed Journal: J Med Chem ISSN: 0022-2623 Impact factor: 7.446